EKF - Ticker AI Digest

EKF Diagnostics Holdings Plc 📰 2
TradingFloor AI GO VIP Login

Digested News

Today's Catalysts (EKF) 2
EKF 13:59
EKF Diagnostics Holdings Plc
Share Buyback
EKF 06:01
EKF Diagnostics Holdings Plc
Share Buyback
AI 0
No items for this category on selected date.
Acquisitions 0
No items for this category on selected date.
Agreement 0
No items for this category on selected date.
Approvals 0
No items for this category on selected date.
Authorisation 0
No items for this category on selected date.
Awards 0
No items for this category on selected date.
BTC 0
No items for this category on selected date.
Blockchain 0
No items for this category on selected date.
Breakthrough 0
No items for this category on selected date.
BuyBack 0
No items for this category on selected date.
Cancellations 0
No items for this category on selected date.
CashOffer 0
No items for this category on selected date.
Collaborate 0
No items for this category on selected date.
ContractWin 0
No items for this category on selected date.
Covid-19 0
No items for this category on selected date.
Deals 0
No items for this category on selected date.
Diamond 0
No items for this category on selected date.
DirectorDealing 1
EKF 06:01
EKF Diagnostics Holdings Plc
Director/PDMR Shareholding
Open AI Digest
Return to today’s catalyst cards, chart beacons and AI charts.
<mark style="background-coloryellow">Purchase</mark> of Ordinary Shares
Discovery 0
No items for this category on selected date.
Exceeded 0
No items for this category on selected date.
FCA 0
No items for this category on selected date.
FDA 0
No items for this category on selected date.
Grants 0
No items for this category on selected date.
InvestmentPlan 0
No items for this category on selected date.
JV 0
No items for this category on selected date.
Launch 0
No items for this category on selected date.
Litigation 0
No items for this category on selected date.
NewContract 0
No items for this category on selected date.
Offers 0
No items for this category on selected date.
Offtake 0
No items for this category on selected date.
Orders 0
No items for this category on selected date.
Partner 0
No items for this category on selected date.
Patents 0
No items for this category on selected date.
Placing 0
No items for this category on selected date.
Positive 0
No items for this category on selected date.
Proposals 0
No items for this category on selected date.
Reports 0
No items for this category on selected date.
Results 1
EKF 06:01
EKF Diagnostics Holdings Plc
Full year results
Open AI Digest
Return to today’s catalyst cards, chart beacons and AI charts.
EKF Diagnostics Holdings plc, an AIM-listed global diagnostics business, released its full-year results for 2024, highlighting a strategic shift towards higher-margin product ranges and core operations. The company reported a 9.2% increase in adjusted EBITDA to £11.3 million, improved gross margins, and stronger cash generation, resulting in a significant improvement in its balance sheet. The companys revenues decreased slightly to £50.2 million due to the discontinuation of lower-margin products, while gross profit remained stable at £24.4 million. The Point-of-Care division, which includes hematology and diabetes products, contributed £31.4 million, while the Life Sciences division, offering contract fermentation services and Beta-Hydroxybutyrate (β-HB) products, generated £16.7 million in revenues. EKF Diagnostics also outlined a five-year strategic development plan focused on accelerating organic growth through operational changes, greater commercial focus, and targeted investments. The company aims to enhance its position in the hematology market and expand its contract manufacturing and fermentation opportunities.
Significant 0
No items for this category on selected date.
Speculation 0
No items for this category on selected date.
Strategic 0
No items for this category on selected date.
Suspension 0
No items for this category on selected date.
TR1 0
No items for this category on selected date.
Takeover 0
No items for this category on selected date.
Understanding 0
No items for this category on selected date.
Updates 0
No items for this category on selected date.
Vaccine 0
No items for this category on selected date.
Wins 0
No items for this category on selected date.
Worth 0
No items for this category on selected date.
All Market News (Last 30 Days) 7
EKF 13:59
EKF Diagnostics Holdings Plc
Share Buyback
EKF 06:01
EKF Diagnostics Holdings Plc
Share Buyback
EKF 06:01
EKF Diagnostics Holdings Plc
Share Buyback
EKF 06:01
EKF Diagnostics Holdings Plc
Share Buyback
EKF 06:01
EKF Diagnostics Holdings Plc
Director/PDMR Shareholding
Open AI Digest
Return to today’s catalyst cards, chart beacons and AI charts.
<mark style="background-coloryellow">Purchase</mark> of Ordinary Shares
EKF 06:01
EKF Diagnostics Holdings Plc
Appointment of CEO
EKF 06:01
EKF Diagnostics Holdings Plc
Full year results
Open AI Digest
Return to today’s catalyst cards, chart beacons and AI charts.
EKF Diagnostics Holdings plc, an AIM-listed global diagnostics business, released its full-year results for 2024, highlighting a strategic shift towards higher-margin product ranges and core operations. The company reported a 9.2% increase in adjusted EBITDA to £11.3 million, improved gross margins, and stronger cash generation, resulting in a significant improvement in its balance sheet. The companys revenues decreased slightly to £50.2 million due to the discontinuation of lower-margin products, while gross profit remained stable at £24.4 million. The Point-of-Care division, which includes hematology and diabetes products, contributed £31.4 million, while the Life Sciences division, offering contract fermentation services and Beta-Hydroxybutyrate (β-HB) products, generated £16.7 million in revenues. EKF Diagnostics also outlined a five-year strategic development plan focused on accelerating organic growth through operational changes, greater commercial focus, and targeted investments. The company aims to enhance its position in the hematology market and expand its contract manufacturing and fermentation opportunities.

AI Crunch

Single-Ticker AI Crunch
EKF signal theatre built from scored market catalysts, automated AI forecasts, and live trigger logic.

This is the ticker-specific AI Crunch desk for EKF Diagnostics Holdings Plc. It compresses bullish and bearish catalyst scoring, best and worst AI forecast paths, and automated buy or sell trigger logic into one cockpit so users can judge conviction without hopping across screens.

Subscription Required Bullish vs Bearish Scoring AI Forecast Stack Buy / Sell Trigger Engine Catalyst Ledger
Create Account Member Login
Subscriber Unlock
Subscribe to unlock the full EKF AI Crunch cockpit.

Subscription turns this tab into a live signal desk with bullish vs bearish machine scoring, AI forecast stack comparisons, buy and sell trigger logic, and the full catalyst ledger behind every scored catalyst row.

  • AI-scored market headlines with sentiment buckets and buzzword breakdowns.
  • Forecast leaders ranked by projected gain against current market price.
  • Advanced technical scans, AI forecast stacks, and predictive MACD inside the live stock terminal charts.
  • Single-ticker AI Crunch desks with buy or sell trigger logic and full catalyst ledgers.
  • Scored earnings shock board with predicted direction, sector pulse and catalyst narrative.
  • Fast market scan built for event-driven trading, not passive dashboards.
Subscribe to unlock the ticker-specific signal stack, sentiment gauges, forecast stage, and the full catalyst ledger for EKF on 2025-04-07.

Fundamentals Matrix

Overall Fundamentals
Signal: Pending
Capital Strength
Signal: Pending
Float Liquidity
Signal: Pending
Short Pressure
Signal: Pending
Target Setup
Signal: Pending
Market Profile
Signal: Pending
Market Cap
107742032
Enterprise Value
182266052
Public Float
83.62
Broker Target
34.667
Shares Out
430953112
Long Interest
100
Short Interest
-
Exchange
LSE
Currency Code
GBX
ISIN
GB0031509804
Market
LSE - AIM
Sector
Health Care
Float / Shares Ratio
-
Short vs Long Delta
-
EV / Market Cap
-

Financials Matrix

Overall Stability
Signal: Pending
Profitability
Signal: Pending
Debt & Cash
Signal: Pending
Valuation Risk
Signal: Pending
Forward Expectation
Signal: Pending
Dividend Safety
Signal: Pending
Divi Rate
-
Ex Divi
2023-11-02
Earnings Date
2026-03-23
Net Debt
-14449000.0
Cash
15834000.0
EPS
-
Net Income
2122000.0
Revenue
51564000.0
Enterprise Value
182266052
Trailing PE
-
Forward PE
34.965
Price Sales TTM
2.0895
Price Book MRQ
1.4979
EV Revenue
1.7673
EV EBITDA
7.2117

Capital Radar

Capital Regime
—
Building signal blend...
Smart Money Tilt
—
Public vs institutions
Target Conviction
—
Broker coverage pulse
Insider Pressure
—
Director + TR1 flow
Last Held Position
-
Public Hands
-
Institutions
14.9728
Institutions As Of
2026-03-19
Avg Broker Target
-
Upside Vs Price
-
Purchase Director Dealing
2
Sale Director Dealing
0
Purchase TR1
0
Sale TR1
3
Broker Coverage Rows
1
Institution Holders Tracked
2
Public Vs Institutional Ownership (3D)
Top Institution Holders (Latest Per Holder)
Director Dealing Sentiment Flow
Broker Target Bias
Signal: Pending
Capital Momentum Matrix
Broker Targets Vs Price
Aggregated Institution Weight By Holder

Short Data - Last 30 Days

Nexus Pulse Engine

Overall Buy/Sell/Hold
Signal: Pending
Technical Composite
Signal: Pending
Financial Composite
Signal: Pending
Fundamental Composite
Signal: Pending
Short Pressure
Signal: Pending
Momentum Bias
Signal: Pending

Volatility Lab

ATR(14)
Realized Vol (20d)
Volume Spike Z

AI Charts

Today's Catalysts

2 live catalysts just hit EKF.

The headlines landing in Digested News are now framed here as today's catalyst tape. Scroll the tab rail to Digested News or jump there instantly below.
Live Tape Data 2025-04-07 AI Charts Landing View
Scroll the tab rail to Digested News any time, or use the jump button to land straight on today's tape.
2 Today
Catalyst Pulse
EKF Diagnostics Holdings Plc has fresh news flow feeding the chart narrative.
13:59 Today's Catalyst Share Buyback 06:01 Today's Catalyst Share Buyback
AI Charts Studio
EKF Price History
Live structure, automated forecasts, technical overlays and catalyst beacons in one chart workspace.
30 Day View Window 30D Data 2025-04-07 Open Preview Studio Brief
Chart Intelligence Suite
Swipe the timeframe, call the overlays, and keep the AI signal stack fused into one chart cockpit.
The mobile chart console is now framed as one connected surface so forecasting, structure, catalyst beacons and chart tools all sit inside the price workspace.

Automated signalling scans momentum shifts, crossovers and volatility breaks in real time. Automated AI forecasts map best, average and worst simulation paths forward, predictive MACD extends the momentum story, and catalyst beacons pin market-moving headlines directly onto price action so users can connect news, signals and structure without leaving the chart.

Automated Signalling Automated AI Forecasts Predictive MACD Catalyst Beacons Live Price Structure
TradingFloor AI Member Login
Indicators0
Technicals0
AI Forecast 28.62%
RSI Gauge
Price Change
AI Forecast